Barclays Portfolio holdings
Barclays PLC, founded in 1690 by goldsmith bankers in London, is a British multinational financial institution headquartered in London, operating as one of the world’s oldest banks with a significant presence in investment banking, retail banking, and wealth management. Managing billions in assets, Barclays serves millions of customers globally through its retail arm (notably in the UK) and its investment banking division, which excels in trading, mergers and acquisitions, and capital markets, competing with Wall Street giants. The bank has navigated challenges like the 2008 financial crisis—opting for private funding over a government bailout—and has since focused on restructuring, digital innovation, and sustainable finance initiatives. With a rich history and a modern global footprint, Barclays remains a key player in both UK and international financial markets.
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
Visa
V
|
+$2.17B |
| 2 |
State Street SPDR S&P 500 ETF Trust
SPY
|
+$1.82B |
| 3 |
iShares Russell 2000 ETF
IWM
|
+$1.37B |
| 4 |
Linde
LIN
|
+$756M |
| 5 |
DuPont de Nemours
DD
|
+$595M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
iShares iBoxx $ High Yield Corporate Bond ETF
HYG
|
+$1.51B |
| 2 |
iShares iBoxx $ Investment Grade Corporate Bond ETF
LQD
|
+$315M |
| 3 |
iPath Series B S&P 500 VIX Short-Term Futures ETN
VXX
|
+$314M |
| 4 |
Microsoft
MSFT
|
+$264M |
| 5 |
PPLI
People Inc
PPLI
|
+$239M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Technology | 9.07% |
| 2 | Financials | 6.12% |
| 3 | Healthcare | 5.17% |
| 4 | Consumer Discretionary | 4.88% |
| 5 | Communication Services | 4.69% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
|
MFNC
4001
DELISTED
Mackinac Financial Corporation
MFNC
| $140K | ﹤0.01% |
14,599
-920
| -6% | -$8.86K |
|
4002
Allient
ALNT
$1.88B
| $139K | ﹤0.01% |
5,031
-1,002
| -17% | -$26.5K |
|
4003
PUT
Liberty Global Class A
LBTYA
$3.6B
| $139K | ﹤0.01% |
6,600
| – | – |
|
4004
CALL
Marvell Technology
MRVL
$196B
| $139K | ﹤0.01% |
3,500
-1,800
| -34% | -$66.2K |
|
4005
OptimizeRx
OPRX
$168M
| $139K | ﹤0.01% |
6,663
-1,298
| -16% | -$22.3K |
|
4006
RCI Hospitality Holdings
RICK
$228M
| $139K | ﹤0.01% |
6,812
-2,769
| -29% | -$43.9K |
|
4007
Spyre Therapeutics
SYRE
$8.94B
| $139K | ﹤0.01% |
785
-140
| -15% | -$25.9K |
|
4008
Alphatec Holdings
ATEC
$1.52B
| $138K | ﹤0.01% |
20,728
-3,804
| -16% | -$21.4K |
|
4009
Gyre Therapeutics
GYRE
$689M
| $137K | ﹤0.01% |
4,268
+2,055
| +93% | +$80.4K |
|
4010
IES Holdings
IESC
$15.1B
| $137K | ﹤0.01% |
4,302
-190
| -4% | -$5.21K |
|
4011
CALL
PVH
PVH
$3.76B
| $137K | ﹤0.01% |
2,300
-3,100
| -57% | -$171K |
|
|
HMHC
4012
DELISTED
Houghton Mifflin Harcourt Company
HMHC
| $137K | ﹤0.01% |
79,130
-29,761
| -27% | -$66.5K |
|
4013
Forestar Group
FOR
$1.5B
| $136K | ﹤0.01% |
7,686
-1,597
| -17% | -$27.7K |
|
|
SINA
4014
CALL
DELISTED
Sina Corp
SINA
| $136K | ﹤0.01% |
3,200
| – | – |
|
4015
eGain
EGAN
$205M
| $135K | ﹤0.01% |
9,571
-2,039
| -18% | -$23.8K |
|
|
HOOK
4016
DELISTED
HOOKIPA Pharma
HOOK
| $135K | ﹤0.01% |
1,433
-105
| -7% | -$10.7K |
|
4017
CALL
Huntsman Corp
HUN
$1.8B
| $135K | ﹤0.01% |
6,100
-11,000
| -64% | -$226K |
|
4018
Nathan's Famous
NATH
$397M
| $135K | ﹤0.01% |
2,628
-6
| -0.2% | -$316 |
|
4019
CALL
Neurocrine Biosciences
NBIX
$15.4B
| $135K | ﹤0.01% |
1,400
| – | – |
|
4020
Peoples Financial Services
PFIS
$716M
| $135K | ﹤0.01% |
3,879
-638
| -14% | -$23.4K |
|
4021
PUT
Phillips 66
PSX
$93.2B
| $135K | ﹤0.01% |
2,600
-1,600
| -38% | -$97.6K |
|
4022
Texas Pacific Land
TPL
$24.6B
| $135K | ﹤0.01% |
2,691
-18,909
| -88% | -$1.13M |
|
|
ACH
4023
DELISTED
Alum Corp of China Ltd
ACH
| $135K | ﹤0.01% |
26,000
+11,200
| +76% | +$69.5K |
|
|
APHA
4024
PUT
DELISTED
Aphria Inc. Common Shares
APHA
| $135K | ﹤0.01% |
30,400
-10,900
| -26% | -$51K |
|
4025
OneSpaWorld
OSW
$2.74B
| $134K | ﹤0.01% |
20,617
-4,430
| -18% | -$26.9K |
|
Similar funds
Barclays's Q3 2020 Portfolio in Review
As of Q3 2020, Barclays held 5,906 positions worth $168B, up 30% from $129B the previous quarter. Its ten largest holdings account for 34% of the portfolio.
Barclays deployed $26.3B of net new capital in Q3 2020, opening 241 new positions and adding to 1,886 existing holdings. Its largest new stake was State Street SPDR Bloomberg High Yield Bond ETF: 771,265 shares worth $80.4M.
By sector, the portfolio is most concentrated in Technology at 9.1% of assets, down from 9.9% a quarter earlier, followed by Financials and Healthcare.
On the sell side, the largest reduction was iShares iBoxx $ High Yield Corporate Bond ETF, an estimated $1.51B trimmed.
- Barclays's largest Q3 2020 buy was State Street SPDR Bloomberg High Yield Bond ETF: 771,265 shares worth $80.4M.
- Barclays added most to Visa in Q3 2020, an estimated $2.17B increase.
- Barclays's biggest Q3 2020 reduction was iShares iBoxx $ High Yield Corporate Bond ETF, cutting an estimated $1.51B.
- Barclays fully exited People Inc in Q3 2020, selling an estimated $239M.
- Barclays's ten largest holdings make up 34% of its $168B portfolio in Q3 2020.
- Barclays opened 241 new positions and closed 676 in Q3 2020.
- Barclays's portfolio value rose 30% quarter-over-quarter to $168B.
Based on Barclays's 13F filing for Q3 2020, filed 12 Nov 2020.